» Articles » PMID: 20444198

Targeted Delivery of NRASQ61R and Cre-recombinase to Post-natal Melanocytes Induces Melanoma in Ink4a/Arflox/lox Mice

Overview
Date 2010 May 7
PMID 20444198
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

We have developed a somatic cell gene delivery mouse model of melanoma that allows for the rapid validation of genetic alterations identified in this disease. A major advantage of this system is the ability to model the multi-step process of carcinogenesis in immune-competent mice without the generation and cross breeding of multiple strains. We have used this model to evaluate the role of RAS isoforms in melanoma initiation in the context of conditional Ink4a/Arf loss. Mice expressing the tumor virus A (TVA) receptor specifically in melanocytes under control of the dopachrome tautomerase (DCT) promoter were crossed to Ink4a/Arf(lox/lox) mice and newborn DCT-TVA/Ink4a/Arf(lox/lox) mice were injected with retroviruses containing activated KRAS, NRAS and/or Cre-recombinase. No mice injected with viruses containing KRAS and Cre or NRAS alone developed tumors; however, more than one-third of DCT-TVA/Ink4a/Arf(lox/lox) mice injected with NRAS and Cre viruses developed melanoma and two-thirds developed melanoma when NRAS and Cre expression was linked.

Citing Articles

Combined inhibition of focal adhesion kinase and RAF/MEK elicits synergistic inhibition of melanoma growth and reduces metastases.

Almazan J, Turapov T, Kircher D, Stanley K, Culver K, Medellin A Cell Rep Med. 2025; 6(2):101943.

PMID: 39922199 PMC: 11866499. DOI: 10.1016/j.xcrm.2025.101943.


Transdermal Delivery of Ultradeformable Cationic Liposomes Complexed with miR211-5p (UCL-211) Stabilizes BRAFV600E+ Melanocytic Nevi.

Chhibber T, Scherzer M, Prokofyeva A, Becker C, Zitnay R, Smith E bioRxiv. 2024; .

PMID: 39484595 PMC: 11527197. DOI: 10.1101/2024.10.17.618694.


Immunotherapy in melanoma: advances, pitfalls, and future perspectives.

Sorino C, Iezzi S, Ciuffreda L, Falcone I Front Mol Biosci. 2024; 11:1403021.

PMID: 39086722 PMC: 11289331. DOI: 10.3389/fmolb.2024.1403021.


Nanotechnology Addressing Cutaneous Melanoma: The Italian Landscape.

Battaglia L, Scomparin A, Dianzani C, Milla P, Muntoni E, Arpicco S Pharmaceutics. 2021; 13(10).

PMID: 34683910 PMC: 8540596. DOI: 10.3390/pharmaceutics13101617.


Genetic analyses in mouse fibroblast and melanoma cells demonstrate novel roles for PDGF-AB ligand and PDGF receptor alpha.

Kadrmas J, Beckerle M, Yoshigi M Sci Rep. 2020; 10(1):19303.

PMID: 33168840 PMC: 7653911. DOI: 10.1038/s41598-020-75774-3.


References
1.
Federspiel M, Hughes S . Retroviral gene delivery. Methods Cell Biol. 1997; 52:179-214. View

2.
Meier F, Satyamoorthy K, Nesbit M, Hsu M, Schittek B, Garbe C . Molecular events in melanoma development and progression. Front Biosci. 1998; 3:D1005-10. DOI: 10.2741/a341. View

3.
Ackermann J, Frutschi M, Kaloulis K, McKee T, Trumpp A, Beermann F . Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background. Cancer Res. 2005; 65(10):4005-11. DOI: 10.1158/0008-5472.CAN-04-2970. View

4.
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M . Cancer statistics, 2009. CA Cancer J Clin. 2009; 59(4):225-49. DOI: 10.3322/caac.20006. View

5.
Barbacid M . ras oncogenes: their role in neoplasia. Eur J Clin Invest. 1990; 20(3):225-35. DOI: 10.1111/j.1365-2362.1990.tb01848.x. View